EMAPALUMAB-LZSG: 132 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
132
Total FAERS Reports
67 (50.8%)
Deaths Reported
36
Hospitalizations
132
As Primary/Secondary Suspect
13
Life-Threatening
2
Disabilities
Prescription
Status
FDA Application: 761107 ·
First Report: 20190216 · Latest Report: 20250313
What Are the Most Common EMAPALUMAB-LZSG Side Effects?
#1 Most Reported
Off label use
51 reports (38.6%)
#2 Most Reported
Septic shock
19 reports (14.4%)
#3 Most Reported
Haemophagocytic lymphohistiocytosis
17 reports (12.9%)
All EMAPALUMAB-LZSG Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 51 | 38.6% | 31 | 20 |
| Septic shock | 19 | 14.4% | 18 | 4 |
| Haemophagocytic lymphohistiocytosis | 17 | 12.9% | 10 | 10 |
| Condition aggravated | 16 | 12.1% | 9 | 8 |
| Death | 13 | 9.9% | 13 | 2 |
| Drug ineffective | 11 | 8.3% | 4 | 5 |
| Pyrexia | 8 | 6.1% | 0 | 2 |
| Gastrointestinal haemorrhage | 7 | 5.3% | 3 | 4 |
| Respiratory failure | 6 | 4.6% | 5 | 3 |
| Seizure | 6 | 4.6% | 1 | 2 |
| Colitis | 5 | 3.8% | 5 | 5 |
| Generalised tonic-clonic seizure | 5 | 3.8% | 4 | 4 |
| Hypotension | 5 | 3.8% | 4 | 4 |
| Multiple organ dysfunction syndrome | 5 | 3.8% | 4 | 2 |
Who Reports EMAPALUMAB-LZSG Side Effects? Age & Gender Data
Gender: 30.3% female, 69.7% male. Average age: 20.1 years. Most reports from: US. View detailed demographics →
Is EMAPALUMAB-LZSG Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 7 | 3 | 1 |
| 2020 | 8 | 4 | 4 |
| 2021 | 3 | 1 | 0 |
| 2022 | 10 | 8 | 4 |
| 2023 | 9 | 5 | 4 |
| 2024 | 16 | 11 | 4 |
| 2025 | 7 | 6 | 5 |
What Is EMAPALUMAB-LZSG Used For?
| Indication | Reports |
|---|---|
| Haemophagocytic lymphohistiocytosis | 76 |
| Product used for unknown indication | 31 |
| Familial haemophagocytic lymphohistiocytosis | 13 |
EMAPALUMAB-LZSG vs Alternatives: Which Is Safer?
EMAPALUMAB-LZSG vs EMEND
EMAPALUMAB-LZSG vs EMICIZUMAB
EMAPALUMAB-LZSG vs EMICIZUMAB-KXWH
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\LINAGLIPTIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\METFORMIN
EMAPALUMAB-LZSG vs EMTRICITABINE
EMAPALUMAB-LZSG vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMAPALUMAB-LZSG vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
Official FDA Label for EMAPALUMAB-LZSG
Official prescribing information from the FDA-approved drug label.